Abstract:Introduction: The importance of deprescribing in clinical practice is growing, particularly in aging populations with polypharmacy scenarios, making it a crucial matter in Portugal, one of Europe's most aged nations. The aim of this study was to investigate deprescribing awareness, training, attitudes, and practices among Portuguese physicians to inform future healthcare strategies. Methods: A cross-sectional study using an anonymous online questionnaire was disseminated through the Portuguese Medical Association. It gathered sociodemographic and professional data, and insights into deprescribing awareness, attitudes, training, and practices. Descriptive statistics were summarized as frequencies, percentages, medians, and interquartile ranges. For inferential analysis, the Chi-square test and Fisher's exact test were used to evaluate categorical variables, and the Mann-Whitney U test was used for continuous variables. The significance level was set at p < 0.05. Results: A total of 425 valid questionnaires were included. The participants were mostly women (61.6%), with a median age of 45 (IQR 34 - 42). General practice/family medicine (34.1%) and internal medicine (16.2%) were the most common medical specialties. While 81.2% of the respondents were familiar with the term 'deprescribing', 55.4% reported no training. A vast majority (91.9%) reported practicing deprescribing, but a smaller fraction employed specific methodologies to deprescribe (39.8%) and criteria for identifying potentially inappropriate medications (38.7%). Training in deprescribing was significantly associated with higher deprescribing awareness (p < 0.001), the use of specific deprescribing methods (p < 0.001), the use of criteria to identify potentially inappropriate medications (p < 0.001) and having certification in geriatrics by the Portuguese Medical Association (p = 0.006). Family physicians showed higher familiarity with and training in deprescribing than hospital-based specialists (p < 0.001). Deprescribing methodologies were adopted more often by family physicians than by hospital-based specialists (p = 0.004). Conclusion: This study highlights widespread deprescribing awareness among Portuguese physicians, while simultaneously uncovering considerable gaps in training and inconsistencies in its application. These findings highlight the pressing need for targeted educational initiatives that could contribute to medication optimization for older adults in the national healthcare system. Furthermore, these findings emphasize the importance of policy development and medical education in promoting safe deprescribing.

Approaches to Deprescribing Proton Pump Inhibitors in Clinical Practice: A Systematic Review

[Deprescribing proton pump inhibitors : what are the clinical practice guidelines ?]

Proton Pump Inhibitors: Rational Use and Use-Reduction – The Windsor Workshop

Improving the feasibility of deprescribing proton pump inhibitors: GPs' insights on barriers, facilitators, and strategies

Clinical impact of medication review and deprescribing in older inpatients: A systematic review and meta‐analysis

The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing

Implementation considerations of deprescribing interventions: A scoping review

Patient-Directed Education to Promote Deprescribing

How could proton pump inhibitors de-prescription be managed in geriatric long-term care?

Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials

Deprescribing Proton Pump Inhibitors: Updated Clinical Guidelines

Medication review and deprescribing in different healthcare settings: a position statement from an Italian scientific consortium

A review of proton pump inhibitor use in cystic fibrosis and considerations for deprescribing

Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review

Consumer Attitudes Towards Deprescribing: A Systematic Review and Meta-Analysis

Prescribing practices for Proton pump inhibitors among primary care physicians in England

The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal

De-Prescribing Proton Pump Inhibitors in Patients With End Stage Kidney Disease: A Quality Improvement Project

Deprescribing in Older Adults: Attitudes, Awareness, Training, and Clinical Practice Among Portuguese Physicians

Deprescribing of proton pump inhibitors in older patients: A cost-effectiveness analysis

Deprescribing potential of commonly used medications among community-dwelling older adults: insights from a pharmacist's geriatric assessment